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Abstract
The Spdeadringer (Spdri) gene encodes an ARID-class transcription factor not previously known in sea urchin embryos. We show that Spdri
is a key player in two separate developmental gene regulatory networks (GRNs). Spdri is expressed in a biphasic manner, first, after 12 h and until
ingression in the skeletogenic descendants of the large micromeres; second, after about 20 h in the oral ectoderm, where its transcripts remain
present at 30–50 mRNA molecules/cell far into development. In both territories, the periods of Spdri expression follow prior territorial specification
events. The functional significance of each phase of expression was assessed by determining the effect of an Spdri morpholino antisense
oligonucleotide (MASO) on expression of 17 different mesodermal genes, 8 different oral ectoderm genes, and 18 other genes expressed
specifically during endomesoderm specification. These effects were measured by quantitative PCR, supplemented by whole-mount in situ
hybridization and morphological observations. Spdri is shown to act in the micromere descendants in the pathways that result in the expression
of batteries of terminal skeletogenic genes. But, in the oral ectoderm, the same gene participates in the central GRN controlling oral ectoderm
identity. Spdri is linked in the oral ectoderm GRN with several other genes encoding transcriptional regulators that are expressed specifically in
various regions of the oral ectoderm. If its expression is blocked by treatment with Spdri MASO, oral-specific features disappear and expression
of the aboral ectoderm marker spec1 encompasses the whole of the ectoderm. In addition to disappearance of the oral ectoderm, morphological
consequences of Spdri MASO treatment include failure of spiculogenesis and of correct primary mesenchyme cell (pmc) patterning in the
postgastrular embryo, and also failure of gastrulation. To further analyze these phenotypes, chimeric embryos were constructed consisting of two
labeled micromeres combined with micromereless 4th cleavage host embryos; either the micromeres or the hosts contained Spdri MASO. These
experiments showed that, while Spdri expression is required autonomously for expression of skeletogenic genes prior to ingression, complete
skeletogenesis also requires the expression of oral ectoderm patterning information. Presentation of this information on the oral side of the
blastocoel in turn depends on Spdri expression in the oral ectoderm. Failure of gastrulation is not due to indirect interference with endomesodermal
specification per se, since all endomesodermal genes tested function normally in Spdri MASO embryos. Part of its cause is interference by Spdri
MASO with a late signaling function on the part of the micromere descendants that is needed to complete clearance of the Soxb1 repressor of
gastrulation from the prospective endoderm, but in addition there is a nonautonomous oral ectoderm effect.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
It is a commonplace that regulatory genes function in
multiple aspects of the developmental process. That is to
say, expression of given regulatory genes is usually required
in more than one spatial and temporal domain of a devel-
oping animal. In these domains, the gene responds to dif-
ferent sets of regulatory inputs, usually impacting different
cis-regulatory modules (Davidson, 2001). The downstream
linkages to target genes within the diverse gene regulatory
network (GRN) subelements in which a given regulatory
gene participates may also differ in its various phases of
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expression. Here, we present a remarkable example: a
newly discovered regulatory gene of the sea urchin embryo
which participates in two entirely separate GRN subele-
ments that operate in nonoverlapping spatial and temporal
domains. The gene, Spdeadringer (Spdri), first participates
in the control of terminal differentiation genes of the skel-
etogenic descendants of the large micromeres. When they
ingress, it ceases forever to be expressed in this cell lineage.
Several hours later, the same gene is activated in the oral
ectoderm. There, it functions as a pivotal player in the
definitive GRN that controls the regulatory state of this
territory during and after gastrulation.
The GRN responsible for specification of the processing
of the skeletogenic primary mesenchyme (pmc) of the sea
urchin embryo is becoming relatively well known (Oliveri
et al., 2002). This GRN transduces the initial maternal
spatial cues presented in the micromeres into a zygotic
regulatory state, and it controls both the signaling and dif-
ferentiation processes executed by the micromere descen-
dants. By midblastula stage, a series of terminal skeleto-
genic genes encoding various cell surface and skeletal
matrix proteins have begun to be expressed, under the con-
trol of a set of zygotic regulators, which are transcribed only
in micromere descendants. Spdri is among these regulators,
though its interrelations with them and the identity of its
direct downstream targets remain to be determined. In con-
trast to primary mesenchyme cell (pmc) specification, the
process by which the oral ectoderm territory is specified has
up to now not been analyzed at a causal level, i.e., consid-
ered in terms of the underlying GRN. Spdri has been par-
ticularly valuable in affording an initial entre´ into this GRN.
Specification of the oral ectoderm territory begins in
early cleavage. Coffman and Davidson (2001) showed that
an asymmetry of redox potential in the zygote correlates
with the future oral/aboral polarity of the embryo, and in S.
purpuratus, by 3rd cleavage this polarity is reflected in the
fates of the blastomeres that give rise to oral and aboral
ectodermal derivatives (Cameron et al., 1989; Henry et al.,
1989; reviewed by Davidson et al., 1998). The boundary
between oral and aboral territories is established only grad-
ually, however. This boundary is the location of the future
ciliated band, which forms after gastrulation is complete.
Signaling inputs from the vegetal plate and most likely
interactions between adjacent aboral and oral ectoderm cells
are required for specification, maintenance, boundary for-
mation, and stabilization of the oral/aboral ectoderm terri-
tories (reviewed by Davidson et al., 1998; Wikramanayake
and Klein, 1995; this work). But Hardin and Armstrong
(1997) and Hardin et al. (1992) showed that, in Lytechinus
variegatus embryos, the oral ectoderm territory is not com-
mitted, in the sense that it is capable of respecification on
experimental challenge until the onset of gastrulation (in S.
purpuratus, this occurs at about 28–30 h). Thereafter, the
oral ectoderm has a distinct cellular phenotype, distinct
functions, and a distinct morphological fate. Definitive oral
ectoderm cells are tall and cuboidal in contrast to the squa-
mous aboral ectoderm, which is also marked by embedded
pigment cells of mesodermal origin. These are excluded
from the oral ectoderm. The oral ectoderm gives rise at the
animal pole end to the neurogenic apical plate, later oral
hood, and just below this where the gut contacts the ecto-
dermal wall to the stomodaeum. The vegetal end of the oral
ectoderm territory abuts the veg1 domain, the oral portion of
which contributes significantly to the larval hindgut in S.
purpuratus (Ransick and Davidson, 1998). A prominent
function of the oral ectoderm with which we are much
concerned in the following is its role in presenting crucial
spatial patterning information to the skeletogenic pmos in
the blastocoel. This information is read by the migrating
pmcs and it accounts for the species-specific form of the
larval skeleton laid down by them (Ettensohn, 1990; Mc-
Clay et al., 1992; Ettensohn and Ingersoll, 1992; Armstrong,
et al., 1993; Armstrong and McClay, 1994; Ettensohn and
McClay, 1986; Hardin and Armstrong, 1997). The oral
ectoderm is defined by a specific regulatory state, the sum of
the output of its GRN: at least from gastrulation onward it
expresses a number of regulatory and other genes, exclu-
sively with respect to the aboral ectoderm, some of which
we discuss below. Among relevant oral ectoderm-specific
regulatory genes are gsc (Angerer et al., 2001), and two
different Nk-class homeodomain genes, nk1 and nk2.1. We
show here that Spdri is linked in a dynamic GRN that
includes all of these genes. This GRN controls the specified
oral ectoderm regulatory state, upon which all known oral
ectoderm properties and functions depend.
Materials and methods
Manipulation of embryos and microinjection of mRNAs
and morpholino-substituted antisense oligonucleotides
(MASO)
The Spdri MASO and a control morpholino-substituted
oligonucleotide were obtained from Gene Tools, Inc. (Cor-
vallis, OR). The sequence of the Spdri MASO was CT-
GTCTTCGCTGGTGTTCAACC. Aliquots at a concentra-
tion of 300 M were prepared by dilution in a 120 mM KCI
solution and used for injection. The goosecoid (gsc) MASO
was a kind gift of R.C. Angerer, and was used at the
concentrations indicated in Angerer et al. (2001).
Eggs were prepared for microinjection as described (Mc-
Mahon et al., 1985; Oliveri et al., 2002). In each injection
(except for Spdri-GFP mRNA), 5 mg/ml lysyl-rodamine-
dextran (Molecular Probes, Eugene, OR) were included in
the solution, so that only successfully microinjected em-
bryos were used in all the experiments performed. Micro-
injection needles were prepared as described by Cameron et
al. (1994). After 6–14 h, embryos displaying rhodamine
fluorescence were collected and cultured until the desired
stage. A sample of the embryos was allowed to develop
until at least 48 h, to assay the morphological effect of the
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injection. In all experiments presented, the effects reported
were observed in more than 95% of cases.
Micromere transplantation experiments were performed
essentially as described by McClay et al. (2000), except that
the embryos were incubated in the hyalin extraction me-
dium (op cit) supplemented with 2–4% BSA at 15°C before
and during the microsurgery.
SpDri cDNA identification, sequencing, Southern blot,
and hybridization assay
A cDNA clone encoding the SpDri protein was identified
in the course of a differential screening aimed to isolate
genes expressed in gastrula stage (40 h) embryos, but not
cleavage stage, following the method described by Rast et
al. (2000). Embryos 7 h old were used as source for the
driver RNA. The sequence of the full-length Spdri cDNA
was reconstructed by aligning overlapping clones. These
were identified by screening arrayed cDNA library filters
(Rast et al., 2000) with a probe obtained by random primer
labeling of the fragment contained in the initial isolate.
Genomic DNA preparation and digestion and genomic
DNA blot hybridization were performed following standard
protocols. The template DNA for the radiolabeling reaction
was obtained by PCR, using the following primers: SpDriE,
5-GGATACTCCAGTGATCCCGA-3; SpDriR, 5-CT-
GCTCCTCAAGAATGAGCCT-3.
Fusion constructs
The Spdri-en fusion construct was obtained by cloning
into a derivative of the BlueScript vector (Stratagene, La
Jolla, CA) an amplified fragment containing nucleotides
531–1004 of the Spdri cDNA (1 is the A of the first ATG).
This fragment includes the entire Spdri DNA binding do-
main (DR-DBD). Primers used for the amplification were
DR-DBD/EN(Xho)up, 5-CTAGCTCGAGCAGAGATG-
GAGACAAACCT-3; and DR-DBD/EN(Xba)down, 5-
TCGATCTAGACCCATGGTGGTATGCCTC-3. The re-
ceiving vector contained the 5 and 3 UTR of the globin
gene (Lemaire et al., 1995) and 888 bp of the engrailed
repressor domain (Li et al., 1999). The fragment was cut
with XhoI and XbaI and ligated to the vector downstream of
the engrailed (en) repressor domain. The transcript was
diluted in 120 mM KCI and divided into aliquots at con-
centrations of 350 or 100 ng/l and used for injection.
Effects of injections were measured in experiments in which
the ratio between the Spdri-en mRNA and the endogenous
Spdri mRNA was about 100:1 at 18 h (this gives about five
times more Spdri-en mRNA than the endogenous Spdri in
the primary mesenchyme cell precursors) and when the ratio
was 15:1 to 20:1 at 28–36 h (this gives about five times
more Spdri-en mRNA than the endogenous Spdri mRNA in
the oral ectoderm territory). These ratios were measured
directly by quantitative PCR (QPCR).
The Spdri-gfp construct was used to check the effective-
ness of the Spdri MASO in blocking Spdri mRNA transla-
tion. It was obtained by cloning a fragment of the Spdri
cDNA extending from 146 to 69 in the sequence up-
stream and in frame with the green fluorescent protein
(GFP) coding sequence used by Arnone et al. (1997). Prim-
ers for the amplification were DR-GFP-Kpn, 5-ATCGG-
TACCGGATACTCCAGTGATCCCGA-3; and DR-GFP-
Aat, 5-CATGACGTCCTGCTCCTCAAGAATGAG-3.
The fragment was cloned by using KpnI and AatI to create
the insertion sites. mRNAs used for injection were tran-
scribed in vitro by using the mMessage mMachine Kit
(Amersham) as per manufacturer’s instructions, and puri-
fied by G-50 chromatography and phenol chloroform ex-
traction and precipitation. The size of the mRNA was ver-
ified by gel electrophoresis, the amount checked by
spectrophotometry, and the proper frame verified by se-
quencing. About 105 mRNA molecules were injected into
each egg.
No clone containing a full-length dri cDNA was ever
isolated by screening of the cDNA libraries or by cloning.
Therefore, the HE:dri fusion construct was obtained by
“fusion PCR” following the technique described by Hobert
(2002). An initial full-length dri was obtained by fusion of
two overlapping dri cDNA clones previously isolated.
These clones (174B22 and 373H21, from the 40-h cDNA
library) overlap for about 400 bp. The PCR amplificate
obtained in this reaction (325; 1356) bore an overhang
of 24 bp with respect to the sequence of the HE promoter at
its 5. A second PCR was set using as template the full dri
amplificate and the HE:gfp plasmid (the use of this plasmid
is described in Rast et al., 2002; the original characterization
of the He promoter was performed by Wei et al., 1995). In
this reaction, the forward primer anneals to the beginning of
the HE promoter sequence. The reverse primer anneals to
the 3 end of the dri cDNA. This primer also bears an extra
sequence at its 3 end to provide polyadenylation sites. The prim-
ers used in these reactions were: Dri-HE, 5-attatcacttcttatcat-
caagctccaagagaaagtgaggaagaatgagtg-3; Dri-SV40, 5-ccgc-
cccgactctagagcctcgagtatgttcggacgaagctccttattttggg-3 for the first
PCR and He-topo, 5-caccgacttgcccttaaattatctggcgtg-3; DRi-
polyA, 5-tttatttatttatttatttatgttcggacgaagctccttattttggg-3 for the
second reaction. The He:gfp construct was obtained by PCR
from the HE;gfp plasmid using as primers for the amplifica-
tion: Flup2, 5-ggacttgcccttaaattatct-3; Fldown3, 5-gcaagta-
aaacctctacaaatgtggta-3. In all reactions, primers were used at a
final concentration of 30 nM and the Expand High Fidelity
PCR System (Roche) was used, following manufacturer’s in-
structions. The sequences of the constructs were checked by
cloning into “pGEMT Easy plasmid” (Promega). In the case of
the He:dri, only partially overlapping clones were obtained.
The reconstructed sequence showed no frame-shifts. Con-
structs were injected into zygotes along with carrier genomic
DNA. The number of molecules injected were 750 molecules/
picoliter for both the He:dri and the He:gfp construct.
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Whole-mount in situ hybridization and antibody staining
Embryos were fixed and whole-mount in situ hybridiza-
tion (WMISH) was carried out as described by Ransick et
al. (1993). Digoxigenin-labeled probes for in situ hybrid-
ization were prepared from the template cDNAs according
to standard protocols. The expression patterns presented
were observed in almost 100% of the cases (exceptions are
due either to over-staining or to complete failure of stain-
ing).
For the staining with the SoxB1 antibody (Kenny et al.,
1999), the -catenin (Logan et al., 1999), and with antibody
recognizing Msp130 (Wessel and McClay, 1985), the em-
bryos were fixed for 20 min in 2% paraformaldehyde sea
water, permeabilized in MetOH for 3 min, then placed in
4% normal goat serum sea water, in which medium they
were also incubated with the antibody. For observation, they
were brought to 30% glycerol, mounted on slides, and
confocally imaged.
RNA isolation, cDNA preparation, and QPCR assays
Total RNA was obtained from the embryos by using
RNAzol (Leedo Medical Laboratories, Inc., Houston, TX),
following manufacturer’s instructions. Genomic DNA con-
tamination was assayed by performing the PCRs with the
ubiquitin primers but without prior retrotranscription.
DNase I (Sigma) was applied in samples where DNA con-
tamination was detected. cDNAs were synthesized by using
TaqMan Reverse Transcription Reagent kit (ABI, Foster
City, CA) according to the manufacturer’s instructions. For
QPCR, the amount of cDNA obtained from 10–20 ng of
total RNA was used for each amplification reaction. Ubiq-
uitin amplifications were carried out on the same samples,
for use in normalization. The “Sybr Green PCR Master
Mix” (ABI) was used for these reactions according to man-
ufacturer’s instructions. Each PCR was performed in dupli-
cate or triplicate. The reactions were monitored by using the
“Gene AMP 5700 Detection System” (ABI). Primers used
in the QPCRs can be found in our Web site under http://
www.its.caltech.edu/mirsky/qpcrprimer.htm.
QPCR data analysis and computation
The “Sybr Green” dye present in the PCR mix fluoresces
when intercalated in the double-stranded PCR product. A
threshold is set within the linear range of the amplification
process (i.e., 0.1 and 0.8 of the terminal value) so that
amplifications that use the same pair of primers but different
cDNA templates (i.e., control and experimental embryos)
can be compared in terms of the number of cycles (Ct)
required to attain the threshold. For duplicate or triplicate
samples, Ct is calculated as the average among the repli-
cates. For each reaction, the average Ct value obtained was
normalized to the average Ct value obtained on the same
cDNA preparations with ubiquitin primers: i.e., · Ct 
Ct(sample)  Ct(ubiquitin). To calculate the effect of the
Spdri MASO or of the Spdri-en fusion mRNA on transcript
levels for each target gene, the difference (D) between Ct for
the control sample and Ct for the experimental sample was
obtained: i.e., D  · Ct(control)  · Ct(experimental). A
positive number indicates an increase in the transcript prev-
alence for the particular marker gene in the experimental
sample, while a negative number indicates a decrease. To
convert D into the ratio (R) of transcript concentration per
PCR (or per embryo), we assume R  1.94D (where 1.94 is
the mass amplification per PCR cycle, for this particular
PCR chemistry and instrumentation).
Phylogenetic analysis
Sequences were aligned by using MacVector 7.0 with
minor corrections done by eye. Phylogenetic analyses were
done by using PAUP v. 4.0b10 for Macintosh. ScSwil was
chosen as the outgroup. The criterion for distance analysis
was minimum evolution, using a heuristic search with tree-
bisection-reconnection (TBR), and distance measure using
mean character difference. The Neighbor-Joining tree was
very similar to the minimum evolution tree. Bootstrap anal-
ysis used 1000 replicates. The quartet puzzle analysis also
used minimum evolution as the criterion and 1000 puzzling
steps were performed. For the parsimony analysis, TBR was
used for the branch-swapping algorithm, and all characters
(74 parsimony informative characters) were unordered and
unweighted. The bootstrap analysis again used 1000 repli-
cates. Bremer support indexes (BSI; Bremer, 1994), a met-
ric which determines how many steps are required for a
node to collapse, were determined by searching for all trees
less than or equal to the specified tree length, and then
computing the strict consensus tree; nodes that collapse are
then given a BSI value equal to the number of steps greater
than the shortest tree. Thus, the maximum parsimony anal-
ysis found a single shortest tree at 400 steps; there are 11
shortest trees less than or equal to 401 steps, and any nodes
which collapsed in this consensus tree are then given a BSI
of 1. There were 35,349 trees 408 steps or shorter, but
because memory limitations precluded additional searches
the highest value determined was 8.
Results
Isolation and characterization of the Spdri sequence
A 2180-nucleotide-long cDNA encoding the SpDri pro-
tein was isolated, and the sequence of the coding region and
of part of the upstream and downstream untranslated re-
gions was obtained as described in Materials and methods.
The sequence has been deposited in GenBank (Accession
No. AY130972). The isolated cDNA clone encodes a pre-
dicted peptide of 452 amino acids, containing a region
highly similar to the DNA binding “A-T Rich Interaction
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Domain” (ARID; reviewed by Kortschak et al., 2000). The
ARID transcription factor family is divided into three major
subgroups, on the basis of the number of conserved -he-
lices contained in the DNA binding domains (Iwahara and
Clubb, 1999). The SpDri protein features the same eight
-helices as found in Drosophila Dead Ringer (Gregory et
al., 1996), mouse Bright (Herrscher et al., 1995) and BDP
(Numata et al., 1999; Kortschak et al., 1998), and human
DriL1 (Kortschak et al., 1998) and DriL2 (Numata et al.,
1999) proteins. In the phylogenetic analysis shown in Fig.
1A, the sea urchin sequence clusters with these members of
the ARID family, with 100% support by three different
algorithms (though the exact topology within the cluster is
not clear). The remarkable conservation of sequence in the
helical regions of these proteins is shown in Fig. 1B. This
subfamily of the ARID transcription factor group recog-
nizes a particular DNA sequence as a target site. Mutation
or knockout of the respective genes results in severe em-
bryonic phenotypes in Drosophila and failures in lymphoid
cell differentiation in mouse (Kortschak et al., 2000).
Spdri is almost certainly a single copy gene. No evidence
of a second gene that cross reacts with the cDNA probe
could be obtained by genome blot hybridization, as shown
in Fig. 1C. DNA from two different individuals, each cut
with three different restriction enzymes, was used in this
experiment. The two individual genomes display either one
or two restriction fragment alleles with each enzyme; i.e.,
they are either homozygous or heterozygous for sites sur-
rounding the unique genomic sequence recognized by the
probe.
Expression of Spdri gene in embryogenesis
The spatial pattern of expression of the Spdri gene, as
revealed by WMISH, is shown in Fig. 2A. The gene dis-
plays two phases of expression: in the precursors of the
skeletogenic or primary mesenchyme cells (pmcs) of the
early to mid blastula; and thereafter in the presumptive and
then the definitive oral ectoderm. The switchover coincides
almost exactly with pmc ingression, which at 15°C occurs
between 20 and 24 h (Fig. 2B and C). Expression in the oral
ectoderm is maintained into the pluteus stage. In the post-
gastrular embryo the domain of Spdri expression includes
the apical plate (Fig. 2C, D, and F) and the ciliary band (Fig.
2F). No staining is visible in any other territories of the
embryo.
An assessment of Spdri transcript prevalence throughout
embryogenesis is given in Fig. 2G. These data were ob-
tained by real time or quantitative PCR (QPCR) measure-
ments (see Materials and methods). There are no detectable
maternal Spdri transcripts. Productive zygotic transcription
begins shortly after 10 h (Fig. 2G). The WMISH data show
that all transcripts after about 25 h are in the oral ectoderm,
and the valley seen in the time course represented in Fig. 2G
from 20 to 25 h is the result of the disappearance of the
transcript from the pmcs. Accumulation of Spdri transcripts
quickly resumes after 25 h, as a result of the transcription of
this gene in the oral ectoderm territory.
Interfering with Spdri function: morphological effects of
an Spdri morpholino oligonucleotide and an Spdri-
engrailed fusion mRNA
A morpholino-substituted antisense oligonucleotide de-
signed to block the translation of the mRNA encoding the
Spdri protein (Spdri MASO) and an Spdri-en fusion
mRNA were injected into zygotes. For controls, a random-
ized morpholino-substituted oligonucleotide, the en mRNA
alone, or gfp mRNA were also injected. Neither the control
morpholino oligonucleotide, the en mRNA nor the gfp
mRNA affected the morphology of the embryo or the ex-
pression of marker genes, as assayed by in situ hybridization
and QPCR. These control embryos were in all ways com-
parable to uninjected embryos (data not shown).
Fig. 3 compares the morphological phenotype of exper-
imental embryos (injected with either Spdri MASO or Sp-
dri-en) with that of controls. The efficacy of the Spdri
MASO is shown in Fig. 3M–P. Here, eggs were injected
with either mRNA encoding GFP (Fig. 3M and O), or a
fusion between gfp mRNA (GFP) and the leader sequence
of Spdri mRNA that initiates the MASO target (Spdri-GFP;
Fig. 3N and P). These eggs also received Spdri MASO
(Fig. 3O and P) or a MASO targeted to a randomized
sequence (Cont MASO; Fig. 3M and N). As can be seen in
Fig. 3O, the Spdri MASO wholly obliterates synthesis of
Gfp from the Spdri-gfp mRNA.
At 24 h, experimental embryos receiving either Spdri
MASO or Spdri-en mRNA look almost normal (Fig. 3A–
C); a slight delay is sometimes observed such that ingres-
sion is retarded in the experimental relative to control em-
bryos. But after ingression is completed, two major
differences become evident: neither the ring of skeletogenic
pmcs that normally forms on the floor of the blastocoel nor
invagination of the archenteron is observed in the experi-
mental embryos. Fig. 3D and G displays invagination of the
archenteron in control embryos. The fully elongated arch-
enteron normally reaches the oral side of the ectoderm by
48 h. Fig. 3E and L and Fig. F and I illustrate the failure to
initiate gastrulation observed in both series of experimental
embryos. These embryos maintain an almost spherical
shape, sometimes showing a slight flattening of the vegetal
plate, but there is never any sign of the inward buckling with
which invagination begins. The bilateral chains of skeleto-
genesis on either side of the gut seen in Fig. 3G are entirely
missing in both the Spdri MASO and Spdri-en embryos of
Fig. 3H and I. No spiculogenesis was observed in the vast
majority of the Spdri MASO embryos.
Further aspects of the phenotype observed upon injection
of Spdri MASO become evident as the embryos approach
72 h of development. The difference between the thick,
cuboidal oral ectoderm and the thin squamous aboral ecto-
derm is seen in the control embryo of Fig. 3J, but the whole
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of the ectoderm of the experimental embryos of this age
appears thin and squamous (Fig. 3K and L). Also at this
time, pigment cells are confined to the aboral ectoderm
territories in the control embryos (Fig. 3J). In contrast,
pigment cells appear to be distributed everywhere in the
embryos injected with Spdri MASO. The uniform squa-
mous ectodermal phenotype and the global incidence of
pigment cells in Spdri MASO embryos both suggest that
oral ectoderm differentiation is abolished by interference
with Spdri expression. These embryos remained alive and
were able to swim for several days. Occasionally, some
Spdri MASO embryos resumed correct pmc patterning,
formed spicules, and gastrulated. Such recovery always
occurred only after a delay of at least a day and was
observed only in a small percentage of embryos.
The later effects were not observed in embryos injected
with Spdri-en mRNA, because (as monitored by QPCR, not
shown) the exogenous Spdri-en mRNA is completely de-
graded by 50 h, and the embryos then recover.
Role of Spdri in the pmc gene regulatory network (GRN)
Spdri would not be expected to affect the specification of
the micromere lineage since, according to Fig. 2, this gene
is not expressed until long after these cells have been set on
their skeletogenic differentiation pathway (Oliveri et al.,
2002). Spdri activation also follows by some hours the
expression in the micromere lineage of the Delta signal
(7th–9th cleavage; Sherwood and McClay, 1999; Sweet et
al., 2002), by which the contiguous veg2 derivatives are
specified to mesodermal fate. Pigment cells are a prominent
mesodermal cell type, the appearance of which is directly
dependent on Delta-stimulated Notch (N) signal transduc-
tion (op cit.; and evidence in Davidson et al., 2002; C.
Calestani, A.R., and E.D., unpublished data). As expected,
the Spdri MASO-treated embryos successfully produce
pigment cells. On the other hand, the total absence of
spicules in these treated embryos suggests that the Spdri
gene functions transiently as a controller of the pmc skel-
etogenic differentiation gene battery (or batteries), though
downstream of the cleavage-stage specification process de-
scribed by Oliveri et al. (2002). Direct evidence of this last
point is that Spdri expression is indirectly dependent on
expression of the major early regulator of micromere spec-
ification, the pmar1 gene, as is expression of all other
known regulatory genes controlling pmc differentiation
functions (Oliveri et al., 2002; and further unpublished
data).
To determine which genes expressed in the pmc lineage
are affected by Spdri, cDNA from embryos expressing Sp-
dri-engrailed mRNA, or bearing Spdri MASO, was ana-
lyzed by QPCR, as described in Materials and methods.
Results are shown in Table 1. The values listed indicate the
difference between experimental and control embryos in the
number of cycles ( · CT) required to attain a threshold level
of PCR product, for each gene listed. For a negative · CT,
the absolute amount of transcript of the gene is lower in the
experimental embryos than in the control embryos by the
factor [1.94 · CT] (see Materials and methods). Several
independent injection experiments were performed at each
time interval. The results shown in Table 1 nicely fit the
initial predictions: the level of transcripts of the pmar1 gene,
which as noted functions upstream of Spdri, is unaffected in
the experimental embryos, and the same is true of delta and
of four pigment cell markers, viz, gcm (Ransick et al., 2002),
decorin, pks, and flvmo (C. Calestani and E.H.D., unpub-
lished data). Nor is the expression of two other pmc regu-
latory genes, which are themselves required for skeletogen-
esis, affected by either Spdri MASO or Spdri-en mRNA,
viz, tbr (Oliveri et al., 2002; Croce et al., 2001), and ets
(Kurokawa et al., 1999, 2000). However, expression of
Spgsc, which has been reported to be expressed in pmcs
prior to their ingression (Angerer et al., 2001), is drastically
reduced in the treated embryos. Table 1 shows that only
about 1.5–3% of the normal level of gsc mRNA is present
in embryos bearing Spdri MASO.
Strong and reproducible effects are observed on the ex-
pression of all the skeletogenic differentiation markers
tested. These are cyclophilin (Zhu et al., 2001; G.A., un-
published data), ficolin (J. Rast and E.H.D., unpublished
data), pm27 (Harkey et al., 1995), sm50 (Sucov et al., 1987,
1998; Benson et al., 1987; Katoh-Fukui et al., 1991; Mak-
abe et al., 1995; Urry et al., 2000), sm30 (George et al.,
1991; Kitajima et al., 1996; Wilt, 1999; Yamasu and Wilt,
1999), and msp130 (Parr et al., 1990). All these genes
evidently require the SpDri factor for their activation. The
Fig. 1. (A) Phylogenetic alignment of members of the ARID family found in human (Hs), Drosophila (Dm), C. elegans (Ce), mouse (Mm), and yeast (Sc)
(referenced in Kortschak et al., 2000) with the sea urchin SpDri protein (in blue). The shortest minimum evolution tree is shown. Bootstrap values (1000
replications) are given: maximum parsimony (MP, top); minimum evolution (ME, middle); and quartet puzzling (QP 1000 steps) (bottom) at each node (see
diagram at bottom of tree). Also indicated are the Bremer support indexes for each node in parentheses after the MP bootstrap value. A dash indicates that
that particular algorithm did not support that node50%. Nodes with no values were not supported by any of the three analyses50%. This analysis strongly
indicates the inclusion of Spdri among the “extended ARID” (eARID) genes and specifically demonstrates the orthology of Spdri and Deadringer protein
sequences. (B) Clustal alignment of the DNA binding domain with the mouse BRIGHT, human DRL1, and D. melanogaster Deadringer. Red residues
indicate identity; green and blue indicate decreasing degrees of conservation. Amino acids shown in black are divergent. SpDri is a member of the eARID
family of transcription factors, featuring eight helices in its DNA binding domain. The green boxes indicate the position of the eight helices (Iwahara and
Clubb, 1999). (C) Genome blot of sperm DNA of two individuals digested with BglII (lanes 1 and 4), DraI (lanes 2 and 5), and EcoRI (lanes 3 and 6), reacted
with a probe corresponding to nt 146 to nt 72 of the Spdri cDNA. The same results were obtained using the full-length cDNA clone inserted as probe
(not shown). The blot reveals that both individuals are homozygous for the BglII fragment containing the Spdri gene, but heterozygous for the other restriction
sites surrounding the gene.
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results recorded in embryos treated with Spdri MASO
were entirely consistent with those obtained upon injection
of Spdri-en mRNA. This indicates that the SpDri protein
normally acts in a positive manner, either directly or by
contributing to the activation of other positive regulators of
skeletogenic differentiation genes. The strongest effects
were on the sm30 gene. Table 1 shows the level of sm30
transcript is depressed by both Spdri MASO and Spdri-en
mRNA to 3% of control. Though sm50 transcript levels
are also severely depressed during the ingression period and
early in the skeletogenic process (16–32 h measurements in
Table 1), at 48 h they are significantly increased in Spdri
MASO embryos. At this time, Spdri is being expressed only
in the oral ectoderm, and the late effect on sm50 expression
is clearly a nonautonomous one.
To confirm the effects of blockade of translation of Spdri
mRNA on skeletogenic matrix genes, we assessed the ex-
pression of sm30 and sm50 by WMISH in treated as com-
pared with normal embryos. The expression of sm30 is
normally observed in pmcs at the time they form bilateral
oral–lateral clusters at the base of the invaginating gut, and
thereafter the activity of this gene is correlated directly with
deposition of the skeletal matrix (Guss and Ettensohn,
1997). As shown in Fig. 4A and B at 48 h, the pmcs of
control embryos express sm30 typically with a bias toward
the oral–lateral clusters (Guss and Ettensohn, 1997). All
detectable sm30 expression is obliterated in embryos devel-
oping from eggs injected with the Spdri MASO (Fig. 4C
and D). This confirms the role of Spdri as a regulatory gene,
expression of which is needed for expression of the sm30
gene. At 48 h, the effect on sm50 expression appears dif-
ferent. Fig. 4G and H shows that sm50 is being expressed in
the pmcs and may even be enhanced in Spdri MASO-
treated embryos, consistent with QPCR data of Table 1 for
this time. Note that those pmcs appear larger than normal,
and perhaps their last division has been suppressed (al-
though this may not be a specific effect).
Requirement of Spdri expression for maintenance of the
oral ectoderm regulatory state
In this section, we provide direct evidence that Spdri
expression is required in order for the oral ectoderm to
preserve and operate its state of specification, and to execute
key oral ectoderm regulatory functions. The initial specifi-
cation of the oral ectoderm occurs long before the Spdri
gene is activated, and indeed in S. purpuratus the initiation
of this process can be traced back to events which have
already taken place by 3rd cleavage (reviewed by Davidson
et al., 1998; Coffman and Davidson, 2001). The specifica-
tion of the oral territory is a progressive process, that in-
volves continuous gene expression and cross-talk between
this and other territories, so that this domain of the embryo
is finally committed only just before the onset of gastrula-
tion (Hardin and Armstrong, 1997). Commitment, as as-
sayed by stability of oral ectoderm differentiation after
microsurgical rearrangement of the embryo, occurs close to
the time when the Spdri gene becomes activated in the oral
ectoderm. This is not a coincidence, as we show in the
following.
A definitive aspect of the committed regulatory state of
the oral ectoderm is maintenance of its distinction from the
surrounding aboral ectoderm. A classical marker of aboral
ectoderm differentiation is the expression of the Spec1 gene,
which encodes a Ca2-binding protein (Hardin et al., 1985;
Tomlinson and Klein, 1990; Gan et al., 1990). After late
blastula stage, this gene is transcribed actively and exclu-
sively in aboral ectoderm illustrated here by WMISH in
48-h control embryos (Fig. 5A and B). Fig. 5C and D shows
that the result of introducing the Spdri MASO is to erase
the difference in the distribution of Spec1 mRNA between
aboral and oral ectoderm. The only unstained area in these
embryos is the vegetal plate, marked by the accumulation of
ingressed pmcs. A similarly drastic result was also observed
in embryos injected with Spdri-en (not shown), though the
effect was less reproducibly obtained because (as shown
from the experiments reported in Table 2, below) Spdri acts
on Spec1 only after 36 h, and the level of the dri-en mRNA
begins to decrease sharply by this time. Nonetheless, it is
clear that upon injection of the dri-en mRNA, the Spec1
gene is again derepressed in the oral ectoderm. This implies
that the SpDri factor does not itself act directly as a repres-
sor of Spec1, but instead activates another gene which
encodes a repressor of Spec1. Were SpDri a direct repressor
of the Spec1 gene, the engrailed fusion would have extin-
guished rather than expanded Spec1 expression. Another
regulatory signature of the oral ectoderm is the expression
of a gene encoding a homeodomain transcription factor,
SpNK2.1 (K.J.P., unpublished data). This gene is normally
expressed in the region that will later differentiate into the
apical plate of the oral ectoderm, beginning at the mesen-
chyme blastula stage. Localization of Spnk2.1 activity in
Fig. 2. Spatial and temporal expression of Spdri gene during embryogenesis. Scale bar, 20 m (all figures are at same magnification). (A–F) WMISH, all
views lateral except (E): (A) Accumulation of Spdri RNA in pmcs resident in the vegetal plate of a prehatching blastula; (B) Spdri transcripts in pmcs as
they ingress at early mesenchyme blastula stage; (C) Spdri expression begins in oral ectoderm in late mesenchyme blastula; no further expression in
completely ingressed pmcs; (D) Strong expression throughout oral ectoderm at prism stage; (E) Expression confined to oral ectoderm, vegetal view. (F) Strong
expression seen throughout oral ectoderm and the ciliary bands at pluteus stage, at the borders between the oral and aboral ectoderm. (G) SpDri transcripts
per embryo, measured by QPCR. The measurements of SpDri transcript prevalence at each stage (see Materials and methods) were converted to molecules
per embryo by reference to an internal standard, i.e., a known amount of transcript prepared in vitro. An additional standard applied to this measurement was
the level of SpZ12 mRNA, measured simultaneously in the same QPCR samples. The absolute amounts of SpZ12 mRNA at different stages were determined
earlier by Wang et al. (1995)..
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control 48-h embryos is shown by WMISH in Fig. 5E. The
effect of the Spdri MASO is here the opposite of its effect
on Spec1 expression. Blockade of Spdri translation results
in loss of all detectable SpNK2.1 expression, as seen in Fig.
5F and G. As we discuss below, this is likely to be due to
direct binding of the SpDri transcription factor to an
SpNK2.1 cis-regulatory element. Finally, Fig. 5H indicates
that transcription of Spdri in the oral ectoderm depends on
the translation of Spdri mRNA, so that the first is abolished
when the second is interfered with. The Spdri gene thus
apparently autoregulates, stabilizing its expression in this
territory once it has been activated. It is interesting that this
does not seem to be the case for Spdri expression in the
pmcs (Table 1).
Fig. 3. Effects of Spdri morpholino oligonucleotide (Spdri MASO) and Spdri-engrailed (Spdri-en) fusion mRNA on development. Eggs were injected with
Spdri MASO (300 M) or Spdri-en (300 ng/l). The embryos are shown in lateral view, except for (L), which is a vegetal view. Embryos are shown from
24 to 72 h of development in the case of control and Spdri MASO embryos, and from 24 to 48 h in the case of dri-en embryos. The developmental time
is indicated in each figure. (M–P) Control experiments, demonstrating that the Spdri MASO arrests translation. (M, N) Introduction of a randomized
morpholino-substituted oligonucleotide, here “cont MASO.” (O, P) Spdri MASO. The embryos also contain gfp mRNA (M, O) or a fusion mRNA that
includes the Spdri leader sequence to which the Spdri MASO is targeted (N, P). (P) The Spdri MASO abolishes the translation of the fusion mRNA.
Table 1
QPCR analysis of mesoderm marker genes
Gene Perturbation 12–16 h 18–21 h 30–36 h 48 h
pmc regulatory genes
delta Dri MASO NS/NS NS/NS
Dri-En NS/NS
dri Dri MASO NS/NS NS/NS
Dri-En NS/NS
Gsc MASO NS, NS NS, NS
ets Dri MASO NS/NS NS/NS
Dri-En NS/NS
gsc Dri MASO 5.0/7.0 7.0/8.6
Dri-En 3.6/2.7
hnf6 Dri MASO NS 1.8/NS
Dri-En NS/NS
pmar1 Dri MASO NS/NS NS/NS
Dri-En NS/NS
tbr Dri MASO NS/NS NS/NS
Dri-En NS/NS
pmc differentiation genes
cyclophilin Dri MASO 2.6/2.7 3.6/NS/1.8
Dri-En 1.8/2.4
ficolin Dri MASO 3.6/NS/2.7/4.6 NS/NS/1.8/2.5
Dri-En 4.6/3.0
msp130 Dri MASO 3.5/5.0 2.0/2.5/3.0
Dri-En 3.6/1.9
pm27 Dri MASO 3.2/5.0 4.0/4.3
Dri-En 3.9/3.9
sm30 Dri MASO 7.5/5.0 5.0/3.2
6.0/6.0
Dri-En 6.2/5.4/5.6/5.6
sm50 Dri MASO NS/3.0/2.1/4.8 NS/2.5/4.0/4.8 4.0/3.0/NS/2.5 4.0/3.4
Dri-En 3.2/2.3
Pigment cell markers
decorin Dri MASO NS/NS NS/NS
gcm Dri MASO NS/NS NS/NS
flvmo Dri MASO NS/NS NS/NS
pks Dri MASO NS/NS NS/NS
Note. Embryos were injected with either Spdri MASO or Spdri-en mRNA and collected at the times indicated. Numbers in each column indicate the
difference in number of cycles (* CT) required to attain threshold in control and injected embryos, after normalization to the amount of ubiquitin mRNA in
the sample. Numbers obtained in different experiments, i.e., from different batches of eggs, are separated by slashes. Where control and experimental values
are less than threefold apart [i.e., difference in (* CT  1.7), the difference is considered not significant (NS; see Davidson et al., 2002b)].
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Results of a series of QPCR experiments on expression
of oral ectoderm genes in embryos treated with Spdri
MASO and Spdri-en mRNA are shown in Table 2. In
addition to the genes utilized for the experiments of Fig. 5,
we also studied the role of Spdri with respect to the expres-
sion of Spbmp2/4 (Angerer et al., 2000), Spgsc (Angerer et
al., 2001), the Splim1 gene (P. Oliveri and E.H.D., unpub-
lished data), Spnk1 (T. Minokawa, unpublished data), and
Spotx1/2 (Li et al., 1997; Yuh et al., 2002), which are all
expressed in the oral ectoderm. Spotp (Simeone et al., 1994)
was also included, on the supposition that this gene is also
expressed in the oral ectoderm as is its orthologue in P.
lividus (Di Bernardo et al., 1999). Further experiments were
carried out with an Spgsc MASO in order to understand
the relationship between Spdri and Spgsc, as the latter has
been reported to play an important role in the specification
of the oral ectoderm (Angerer et al., 2001).
The data in Table 2 are entirely consistent with the
WMISH experiments shown in Fig. 5. Thus, at 48 h, treat-
ment with Spdri MASO results in an increase in Spec1
transcription by a factor of 2–4, as might be expected from
the expansion of the domain of Spec1 transcription over the
whole of the oral ectoderm, including apical plate (Fig. 5C
and D). Similarly, both Spdri MASO and Spdri-en mRNA
cause an 80–90% decrease in SpNK2.1 transcript (see Fig.
5E and F), and both treatments have this or even greater
effect on transcription of the Spdri itself (see Fig. 5H). This
confirms the implication that the Spdri gene is involved in
an autoregulatory loop after its expression is established in
the oral ectoderm (30–48 h) though not earlier (24–27 h).
Table 2 shows that Spdri does not at all affect two of the
genes tested, though they are expressed significantly in the
oral ectoderm at the times assayed, viz, Splim, and bmp2/4.
However, expression of four other genes encoding oral
ectoderm transcription factors is depressed similarly by both
Spdri MASO and Spdri-en mRNA, viz, gsc, nkl, otp, and
otx1/2. The Spdri gene evidently performs a positive reg-
ulatory function responsible for at least 80% or so of the
normal levels of transcript for all four of these genes. Note
that in all cases there is again little or no such affect until the
30- to 36-h period, some hours after Spdri itself, and these
genes as well, are switched on in the oral ectoderm. The
case of gsc is particularly interesting, for the gsc MASO
depresses Spdri transcript levels as well as vice versa. These
two oral ectoderm genes are evidently locked into a positive
regulatory embrace, so to speak.
The maintenance of the regulatory state of the oral ec-
toderm is a function of the expression of Spdri. This trans-
lates to the need of Spdri expression for the activation of
several important transcription factor genes in this territory,
as we have shown above. However, the question remains
whether or not expression of Spdri is sufficient, or only
necessary, for activation of its target genes. To answer this,
we set out to express Spdri under the control of the Hatching
Enzyme (HE) cis-regulatory element (Wei et al., 1995; Rast
et al., 2002). Injecting the He:dri construct into zygotes
produces normally developing embryos that contain clones
of cells, which transcribe Spdri outside of its normal domain
of expression. The success of these injections can be visu-
Fig. 4. Expression of skeletogenic matrix genes in embryos treated with
Spdri MASO. WMISH is displayed in 48-h embryos, viewed laterally (A,
C, E, G) or from the blastopore (B, D, F, H); (A–D) sm30 probe; (E–H)
sm50 probe. (A, B) Normal embryos in which most pmcs express sm30, at
various levels (A) oral–lateral pmc clusters can be seen clearly. (B) pmcs
arranged in syncytial chains, in process of depositing skeletal rods. (C, D)
Embryos bearing Spdri MASO. No sm30 expression can be detected in
any of the pmcs, though these have completed ingression into the blasto-
coel. (E, F) 48-h controls showing some pmcs expressing sm50. (G, H)
Embryos of the same age bearing Spdri MASO overexpress the sm50 gene.
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alized in living embryos, by coinjecting an He:gfp construct
(Fig. 6B and C). In sea urchin embryos, exogenous DNA
fragments are ligated together into one or a few concate-
nates before insertion in the genomic DNA (Livant et al.,
1991; Arnone et al., 1997) so that the cells that express gfp
also express dri. Embryos were allowed to develop until
after 24 h, then checked for fluorescence, fixed, and assayed
for the expression of dri, gsc, nkl, and nkx2.1 by WMISH to
determine whether any of these genes would also be tran-
scribed ectopically. The experiment shown in Fig. 6 dem-
onstrates that ectopic Spdri is not sufficient for the expres-
sion of gsc, nkl, or nkx2.1. Here (Fig. 6F and I), 30- to
32-h-old embryos are shown to express Spdri in a patch of
cells that lies outside of the oral ectoderm, upon injection of
the He:dri construct (cf. Fig. 6F and I to Fig. 6D and G, and
Fig. 6E and H). However, none of the other marker genes
assayed showed any difference in their domains of expres-
sion as compared with uninjected embryos or embryos in-
jected just with the He:gfp construct (cf. Fig. 6J, K, M, N,
P, Q, S, and T with L, O, R, and U).
Indirect role of SpDri in vegetal plate specification and
gastrulation
Interference with translation of Spdri mRNA results in
the failure of the embryo to gastrulate (Fig. 3). To determine
whether this is due to an indirect effect on the state of
endomesodermal specification just before gastrulation, we
analyzed the expression of 18 vegetal plate genes by QPCR,
as shown in Table 3. Evidence regarding the participation of
these genes in endomesodermal specification is given in
Davidson et al. (2002a,b). In the experiments of Table 3,
two batches of embryos were injected with Spdri MASO
and sampled at 18, 28, and 32 h. Various pmc and oral
Fig. 5. Regulation of ectodermal genes by Spdri, assayed by WMISH at 48 h. (A, C) Lateral views; (B, D) vegetal views. (A, B) Expression of Spec1, controls.
As demonstrated in numerous earlier works (see text for references), expression of Spec1 is normally confined to the aboral ectoderm, and does not occur
in gut, pmcs, or oral ectoderm. (C, D) Expression of Spec1 in embryos in which translation of Spdri is blocked. The result is to derepress the Spec gene
throughout the oral ectoderm territory, as most clearly seen in (D): There is now no nonexpressing ectodermal domain (compare the oral ectoderm region
in B, i.e., that region toward which the gut bends). The only cells not expressing the Spec1 gene in (C) are noninvaginated endoderm (see text), and ingressed
pmcs. (E, F) Effect of Spdri MASO on the expression of the SpNK2.1 gene. (E) Normal control. Expression is sharply confined to the apical domain of
the oral ectoderm. (F, G) Spdri MASO-injected embryos: All detectable expression is abolished (G, lower magnification of a field of embryos). (H) Effect
of Spdri MASO injection on Spdri transcription. The total lack of expression demonstrates the autoregulation of Spdri in the oral ectoderm; compare Fig.
2D and E.
Table 2
Regulation of oral ectoderm genes by Spdri, assayed by QPCR
Gene Perturbation 24–27 h 28–30 h 30–36 h 48 h
bmp2/4 Dri MASO NS/NS NS/NS
dri Dri MASO NS/NS/NS 2.7/5.0 4.5/1.8/4.5/3.0/2.5/2.8/5.0 4.5/3.8
Gsc MASO NS/NS 2.4/6.0 3.8/4.5
Dri-En MOE 2.3 2.5/2.3
gsc Dri MASO NS/NS NS/3.3 3.0/4.0/2.5/3.0/4.0/3.0/3.0/3.2/3.0 3.0/2.5
Gsc MASO NS/NS NS 3.2/3.5/3.1/2.0
Dri-En MOE NS 3.5/3.8/1.8/2.0
lim Dri MASO NS/NS/NS/NS NS/NS NS/NS/NS NS/NS
NS/NS NS/NS/NS
Gsc MASO NS/NS/NS/NS NS/NS NS/NS/NS
NS/NS NS/NS
Dri-En MOE NS NS NS/NS/NS/NS/NS/NS
nk1 Dri MASO NS/NS/NS 2.2 2.2/2.3/2.2/3.3/3.5/4.2/5.0/7.0/3.3 2.8/2.4
Gsc MASO NS/NS/NS 2.6 2.6/3.2/4.0/5.0/6.0/2.5 2.8/2.4
Dri-En MOE 2.0 5.7/5.1/4.6/2.5
nkx2.1 Dri MASO N/NS/NS NS/NS 4.2/4.0/3.0/3.8 2.3/3.7
Dri-En MOE NS 3.3/2.8/2.3/NS
otp Dri MASO NS/NS 4.0/3.8 6.8/8.0
Dri-En MOE 1.9
otx1/2 Dri MASO NS/NS 3.2/3.0 4.0/3.8 3.5/4.1
spec1 Dri MASO NS/NS/NS/NS NS/NS/NS NS/NS/NS/NS 1.5/2.2
Gsc MASO NS/NS
Dri-En MOE NS NS/NS/NS/NS/NS
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ectoderm markers were also assessed in the same embryo
batches, with results (not shown) identical to those already
presented in Table 1. No one of the endomesodermal spec-
ification genes is significantly affected by Spdri MASO
around the period when gastrulation occurs, i.e., 28–30 h,
with the exception of the krl gene (Howard et al., 2001).
Expression of krl is clearly stimulated by Spdri MASO. At
this stage, krl is expressed in veg1 (T. Minokawa and
E.H.D., unpublished data; and this report; see below), which
will soon invaginate to form (mainly) hindgut.
The main import of Table 3 is straightforward: the in-
terference with gastrulation seen in embryos bearing Spdri
MASO (Figs. 3–5) is clearly not due to an early effects on
any of the known endomesodermal regulatory or signaling
genes. Expression of most of these genes is required for
gastrulation (Davidson et al., 2002a,b), but the hypothesis
that Spdri (indirectly) affects the gene regulatory state lead-
ing to gastrulation can be rejected, at least with respect to
the known components of that state.
As an illustration of this point, in Fig. 7, the pattern of
expression of three regulatory genes, evenskipped (eve)
(Ransick et al., 2002), brachyury (bra) (Gross and McClay,
2001), and krl (Howard et al., 2001), as well as that of
endo16 (Ransick et al., 1993) is shown in Spdri MASO
and control embryos. At 30 h in controls, gastrulation is just
beginning: the first two genes are both expressed in a ring
above the initially invaginating veg2 progeny (Fig. 7A and
C), while in the slightly older embryo shown in Fig. 7E, a
clear staining for endo 16 marks the whole of veg2. Al-
though the Spdri MASO embryos show no morphological
signs of gastrulation, the same sets of cells appear to be
expressing these genes as in the controls (Fig. 7B, D, and F).
In contrast, when looking at the pattern of expression of krl,
Fig. 6. A test for sufficiency of Spdri expression for activation of down-
stream genes. Normal embryo (A, D, G, J, M, P, S), He:gfp-injected
embryos (B, E, H, K, N, Q, T), and He:gfp; He:dri coinjected embryos are
compared. (A–C) Live embryos; in (B, C), the gfp fluorescence is super-
imposed on the bright field image. In (C), this coincides with the site of
activation of He:dri. (D–U) WMISH displays shown in 30- to 32-h em-
bryos viewed laterally except in (G–I) and (M–O), where the embryos are
viewed from the vegetal plate. Developmental times and probes used are
indicated in each panel. In (F) and (I), arrowheads indicate the site of the
ectopic He:dri expression. No obvious ectopic gsc (L, O), nkl (R), or
nkx2.1 (U) expression is ever observed
Table 3
Effects of Spdri MASO injection on genes encoding endomesodermal
transcription factors and signaling components, assessed by QPCR
Gene 18 h 28 h 32 h
gatac 2.1/2.3a NS/NS NS/NS
gatae NS/NS NS/NS NS/NS
foxa NS/NS NS/NS NS/1.9
bra NS/2.3 NS/NS NS/NS
eve NS/2.4 NS/NS NS/NS
hox11/13b NS/NS NS/NS NS/NS
gcm NS/NS NS/NS NS/NS
hmx 2.0/2.4a NS/2.6 NS/NS
e(s) NS/NS NS/NS NS/NS
notch NS/NS NS/NS NS/NS
wnt8 NS/NS NS/NS NS/NS
krl NS/NS 3.7/3.1 3.6/3.5
otx NS/NS NS/NS NS/NS
su(h) NS/NS NS/NS NS/NS
nrl NS/NS NS/NS NS/NS
foxb NS/NS NS/NS NS/NS
not NS/NS NS/NS NS/NS
elk NS/NS NS/NS NS/NS
a gatac and hmx are barely activated at this time and these measurements
are not meaningful; they may indicate only a likely slight retardation.
69G. Amore et al. / Developmental Biology 261 (2003) 55–81
important differences can be seen between Spdri MASO
and control embryos. At the beginning of gastrulation, sim-
ilarly to bra and eve, krl is expressed in the ring of veg1 cells
that border the site of the first invagination. Soon after that,
however, this pattern changes so that only the most oral of
the veg1 cells will maintain krl expression in control em-
bryos (T. Minokawa and E.H.D., unpublished results; and
Fig. 7G and I). This later change is never seen in the Spdri
MASO-injected embryos, which maintain a high level of krl
expression throughout the whole veg1 tier (Fig. 7H and J).
This is why higher levels of krl in the injected embryos are
observed (see the QPCR measurements reported earlier).
All in all, these results show that early specification events
in the vegetal plate proceed undisturbed in the Spdri
MASO-injected embryos.
One clear and though indirect effect of the early phase of
Spdri gene expression in the pmc domain has been detected,
however. This is an effect on a late phase of pmc signaling to
the surrounding endomesoderm. As to be described elsewhere
in detail, the “early” micromere signal to the macromeres and
veg2 (Ransick and Davidson, 1993, 1995) is required for the
initial clearance of Soxb1 protein from a disc of about 7–8
cells in diameter. The soxb1 protein present in the embryo
during cleavage and blastula stages is translated from a copious
maternal mRNA (Kenny et al., 1999). Very little of the ma-
ternal soxb1 mRNA is present in the micromeres ab initio,
which consequently contain little of the protein, probably be-
cause they inherit only a small volume of maternal cytoplasm
(Kenny et al., 1999). Fig. 8A–C illustrates the disc of vegetal
cells that lack Soxb1 during the middle period of the blastula
stage, as a result of the early signal. This disc includes the
immediate descendants of the micromeres, but also some or all
of the future veg2 mesodermal precursors (Ruffins and Etten-
sohn, 1996). As shown in Fig. 8A–C, in which Soxb1 protein
is visualized by immunocytology, the cleared region remains
constant in width at 6–8 cells from 12.5 to about 18.5 h. Then,
within the next 2 h, it expands to a diameter of 12 cells, now
including essentially all the veg2 prospective endoderm (Fig.
8D). In embryos treated with Spdri MASO, the initial phase
of clearance promoted by the early micromere signal takes
place normally (Fig. 8E and F). But the expansion of the
cleared zone to the endoderm then fails, and at 20.5 h in these
embryos the disc remains just 7 cells wide (Fig. 8H), as
observed in a number of independent experiments. Note that
the treated and control embryos have about the same number
of cells. Late vegetal clearance of Soxb1 is clearly an indirect
function of Spdri expression in the micromere descendants,
since this gene is never expressed in any veg2 cells. This
observation accounts in part for the ultimate failure of gastru-
lation in Spdri MASO-treated embryos, as we discuss below.
Separate functions of Spdri in pmc and oral ectoderm
territories, as revealed in chimeric embryos
In order to assess independently the functions of Spdri in
its two distinct phases of expression, we turned to the use of
Fig. 7. Expression of endodermal genes in embryos treated with Spdri
MASO. WMISH displays are shown in 30-h embryos viewed laterally
(A–H) and vegetally (I, J). (A, B) bra probe; (C, D) eve probe; (E, F) endo
16 probe; (G–J) krl probe. (A, C, E, G, I) Normal embryos and (B, D, F,
I, K) treated embryos showing the veg1 staining of the probes.
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chimeras, consisting of embryos in which either the micro-
meres or the remainder of the embryo contained Spdri
MASO. The two different forms of chimeras were created
as follows: two micromeres from an embryo bearing Spdri
MASO (and fluorescently stained) were combined with a
micromereless normal or control embryo (Morpholino Mi-
cromere/Control Embryo; MM/CE); or two micromeres
from a normal control embryo were combined with a mi-
cromereless embryo bearing Spdri MASO (Control Micro-
mere/Morpholino Embryo; CM/ME). Fig. 9 displays an
illuminating series of results. We see in Fig. 9A and B that
expanded Soxb1 clearance in veg2 indeed requires normal
micromeres, confirming that this is an indirect function of
late micromere signaling, which is dependent on Spdri ex-
pression in the micromere descendants (Fig. 9A; cf. Fig. 8).
Nor does interference with translation of Spdri mRNA pre-
vent the response to this signal in the recipient veg2 cells
(Fig. 9B). Fig. 9C–J address the skeletogenic patterning
functions executed by the pmcs once they have ingressed.
Pmc’s descendant from micromeres carrying Spdri MASO
successfully ingress (Fig. 9C and D), but they fail to form
the normal ring on the bottom of the blastocoel. Such a ring,
visualized from the vegetal pole, is shown in a 36-h CM/ME
chimera in Fig. 9E. This result incidentally indicates that
Spdri expression in the oral ectoderm is not needed to
provide cues for the initial formation of the skeletogenic
ring. But it is needed in the micromeres in order for them to
read the animal/vegetal cues that normally determine the
positioning of this ring. Instead of forming a vegetally
located ring, in the 36-h MM/CE chimeras of Fig. 9C and D,
the micromere descendants are positioned all about the
blastocoel, as far up as the animal pole. By 56 h in the
MM/CE chimeras, some unlabeled secondary mesenchyme
cells have converted to skeletogenic fate (Ettensohn and
McClay, 1988) and can be seen to be participating in for-
mation of normal-looking syncytial skeletogenic chains (ar-
rowheads) which are bilaterally organized (Fig. 9F and G).
However, the micromere descendants, containing Spdri
MASO, identified by their fluorescent stain are not included
in these formations, and as indicated earlier, these pmcs are
unable to express skeletogenic genes at normal levels or to
carry out skeletogenesis. They continue to wander about the
blastocoel and fail to form the oral lateral clusters where
skeletogenesis is initiated. Whatever contributions Spdri
expression make to differentiation of oral ectoderm territo-
rial identify are not required for formation of these clusters,
since this takes place in CM/ME chimeras (Fig. 8H). Later,
however, an important oral ectoderm patterning function
that is dependent on Spdri expression can be identified.
Comparison of the skeletogenic pattern identified in blue in
the CM/ME chimera (Fig. 9I) with that of the control em-
bryo (Fig. 9J) indicates that the chimera completely lacks
the oral rod (white arrowheads in Fig. 9J). Expression of
Spdri in the oral ectoderm is evidently required to impart the
patterning information to the skeletogenic pmcs needed for
oral rod formation. These 72-h-old CM/ME embryos also
show a normal polarization of the ectoderm along the oral/
aboral axis. This is probably obtained through regulation
made possible at this late time, by the presence of intact
Fig. 8. The effect of Spdri MASO on vegetal clearance of Soxb1. Confocal images of blastula-stage embryos display nuclear Soxb1 protein by fluorescence
immunocytology (green), at the indicated times after fertilization. (A–D) Normal controls; (D–H) embryos bearing Spdri MASO. The numerals indicate the
diameter, in cells, of the region from which the Soxb1 protein has been cleared.
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vegetal signaling. This recovery is never seen in MASO-
injected embryos (Fig. 3K and L).
Further observations on these chimeras are shown in the
WMISH experiments of Fig. 10. Here, probes recognizing
Spdri and sm30 mRNAs were applied together to the chi-
meras. Both the oral ectoderm and the pmc clusters are
therefore stained in the 36-h control embryos shown in Fig.
10A and B. Chimeras formed from normal components
(CM/CE; i.e., containing no Spdri MASO) develop iden-
tically to normal embryos and display the same normal
patterns of staining (Fig. 10C and D). As expected from the
foregoing, Spdri MASO poisoned micromeres give rise to
pmcs that fail to express sm30, though in the MM/CE
chimeras the Spdri gene continues to be expressed normally
in the oral ectoderm (Fig. 10E and F). But the interdepen-
dence of the two territories is shown strikingly in the ex-
periments of Fig. 10G and H. Though the micromeres in-
gress normally in the CM/ME chimeras of Fig. 9G and H,
Fig. 9. Observations on Spdri MASO chimeras. Chimeras were constructed by recombining two micromeres with micromereless hosts at the 16-cell stage.
In all cases, donor micromeres were labeled with fluorescent dye. False color confocal images of the chimeras are shown. Either the donor micromeres or
the host embryos were derived from eggs injected with Spdri MASO. (A, C, D, F, G) Chimeras obtained by transplanting Spdri MASO micromeres to
control micromereless host embryos (MM/CE). (B, E, H, I) Chimeras obtained by transplanting normal micromeres to micromereless Spdri MASO host
embryos (CM/ME). The developmental time is indicated in each of the figures. (A, B) Chimeras were fixed at 20 h, and stained for -catenin to indicate cell
boundaries (red) and for SoxB1 (green). (C–H) Images of living chimeras. The red color indicates pmc’s descendant from donor micromeres, to display their
arrangement inside the embryo. Arrowheads in (F–H) indicate the position of oral–lateral pmc clusters. In (F) and (G), these clusters are formed from
converted host smc’s, since the cells that form them are not fluorescently labeled. Host’s pmcs bearing Spdri MASO remain scattered and are unable to
participate to spiculogenesis. In (H), the pmc clusters are formed by the normal donor pmcs. (I, J) 72-h embryos stained for -catenin (red) and the
pmc-specific cell surface protein msp130 (blue). (I) CM/ME chimeric pluteus. The skeletal pattern indicated by the blue stain indicates the normal pair of
body rods. The oral rods are missing (the dotted white lines indicate the site where the oral rods should be). (J) Normal control embryo. The arrowheads
indicate one of the oral rods.
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their pmc descendants fail to turn on the sm30 gene: for this
to occur, they evidently must read a signal presented on the
blastocoelar surface of the oral ectoderm, and in the absence
of the SpDri factor, this oral ectoderm function is evidently
not executed. Note in addition that (as indicated in the
QPCR experiments of Table 2) maintenance of Spdri ex-
pression itself in the oral ectoderm requires SpDri, and thus
in the CM/ME embryos of Fig. 10G and H, no WMISH
staining is detectable in the oral ectoderm either. Further-
more, Fig. 10I and J show that initial activation of the Spdri
gene in the oral ectoderm requires the prior presence of
micromeres. This could of course be an indirect effect of
micromere signaling to the vegetal plate and to its precur-
sors (reviewed by Davidson et al., 1998, 2002b). Activation
of Spdri in the oral ectoderm is independent of its expres-
sion in the micromere descendants, however (Fig. 10E
and F).
Figs. 9 and 10 show clearly that both MM/CE and
CM/ME chimeras are capable of gastrulation and indeed
this occurs in at least 85% of cases. Yet, whole embryos
bearing Spdri MASO fail to gastrulate (Fig. 3). A possible
key to of this apparent paradox devolves from the measure-
ments of Table 4. These show that the archenterons that
form when MM/CE chimeras do gastrulate have only about
60% of the number of cells of normal embryo archenterons
or of CM/ME chimeras (the archenterons are all the same;
to see this compare Fig. 9E and G and Fig. 10F and H).
Thus, the two different kinds of chimeras construct their
archenterons differently. There are some possible interpre-
tations which we briefly discuss below.
Discussion
Role of Spdri in the micromere/pmc GRN
The micromere/pmc GRN (Oliveri et al., 2002) carries
out three general functions in succession. Its initial job is to
transduce cues localized to the micromeres by the time these
are born into a zygotic state of gene expression that will lead
Fig. 10. Expression of Spdri and sm30 in 36-h control and Spdri MASO
chimeric embryos assayed by WMISH. Probes for Spdri and Sm30 were
mixed and hybridized together to the embryos. (A, C, E, G, and I) Lateral
views; (B, D, F, H, and J) Vegetal views. (A, B) Control embryos; (C, D)
Sham chimeras (normal micromeres were transplanted to normal micro-
mereless embryos). (E, F) MM/CE chimeras in which Spdri MASO
micromeres were transplanted to control micromere-less embryos. (G, H)
CM/ME chimeras in which control micromeres were transplanted Spdri
MASO host embryos. Note the different width of the gut in the two kinds
of chimeras (i.e., E, F vs. G, H). (I, J) Micromereless embryos.
Table 4
Cross-sectional dimensions of chimera archenterons
Number of cells in the circumference of chimera archenterons
Control CM/ME MM/CE
16 18 11
18 17 10
16 16 10
16 17 9
Approximate diameter of the archenterons
23 26 17
25 25 17
26 27 18
25 27 16
26 23 16
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to specification. This it does by means of the pmar1 regu-
latory gene, which is expressed uniquely in the micromeres
and their immediate descendants. Expression of pmar1 has
multiple consequences: a cohort of regulatory and signaling
genes is specifically activated in the micromere lineage,
which essentially constitutes the specification of this lin-
eage. Activation of these genes is the second major function
of the micromere/pmc GRN. These genes are initially in a
state of embryo-wide global repression, which is relieved
specifically in the micromere lineage by the pmar1 gene
product, itself a repressor. It permits specification by pre-
venting the gene(s) encoding the global repressor(s) from
operating in this particular lineage. Among the genes acti-
vated in consequence of pmar1 expression are two genes
encoding micromere signaling ligands, one the Notch ligand
Delta (Sweet et al., 2002; Oliveri et al., 2002) and the other
an unknown ligand, the “early” micromere signal to veg2
that is required for normal endomesodermal specification to
be initiated in veg2 (Ransick and Davidson, 1993, 1995).
We now know that one function of the early signal is to
effect the clearance of Soxb1 from the central ring of veg2
cells (D.R.M., P. Oliveri, and E.H.D., unpublished data).
This clearance is illustrated in Fig. 7A and B. A suite of
genes encoding positively acting transcriptional regulators
required for skeletonization is also activated in the descen-
dants of the micromeres, though not synchronously. Some,
for example, tbr, go on soon after the micromere lineage is
founded and pmar1 begins to be expressed (4th cleavage is
complete at about 5 h). In contrast, as shown in Fig. 2, Spdri
is not activated in the micromere descendants until about
12 h. This suggests that an additional regulatory step could
lie between the installation of the pmar1 derepression sys-
tem and Spdri activation, though this is not necessarily the
case. While its expression is transient, pmar1 transcripts are
still present in the micromere descendants when the Spdri
gene is activated. In any case, it is clear, as reported by
Oliveri et al. (2002), that Spdri belongs to the set of genes
activated in consequence of the pmar1 derepression system.
Spdri is dramatically derepressed in embryos in which
mRNA encoding either Pmar1 or a Pmar1-engrailed fusion
is present ectopically, just as are tbr, delta, and other genes
under pmar1 spatial control depressed. So far as upstream
connections go, these observations approximately locate
Spdri in the micromere/pmc GRN.
The third general function of the micromere/pmc GRN is
to accomplish the activation of pmc differentiation genes.
The evidence in Table 1 of this paper (see also Fig. 3) shows
that Spdri is a required participant in this process. Note that
Spdri affects no other of the known skeletogenic regulatory
genes active in the micromere lineage just prior to ingres-
sion, except for gsc (the relation between Spdri and gsc is
discussed below). The important point in Table 1 is that
interference with Spdri expression causes severe depression
in the level of transcripts of every one of five skeletogenic
Fig. 11. Elements of a provisional GRN for the postgastrular oral ectoderm. (A) “View from the genome” (VFG; Bolouri and Davidson, 2002) in which all
the interactions are shown at once. An “Oral Activator” (whose activity depends on vegetal signaling) is responsible for initial activation of Spdri in the oral
ectoderm. Several Additional Imputs (AIs) are imagined to be required for the proper spatial control of each of the Spdri target genes. The requirement for
inputs in addition to Spdri has been demonstrated for gsc, nk1, and nkx2.1 (Fig. 6). We propose here that the same applies to otxb1/2, otp, and repressor B.
The sign of these inputs could be either positive (input active in the domain of expression of each particular gene considered) or negative (active outside of
the domain). The origin of these inputs may or may not be other genes considered in the diagram. An additional repressor (AR) is also imagined to account
for the repression of “repressor A” in the apical plate and ciliary band, where gsc is not expressed, but dri is. Spec1 is kept silent in the oral ectoderm by
the activity of OER, a repressor that interferes with the positive function of Otx and CBF (Yuh et al., 2001). Though these observations of Yuh et al. were
made on the Spec2a gene, its expression, like that of Spec1, is dependent on a similar cis-regulatory cassette (Gan et al., 1990). (B–E) “Views from the nuclei”
(VFNs) show the interactions at two different times and in four different spatial domains, as indicated. Arrows indicate positive cis-regulatory inputs; barred
lines indicate repressive inputs. Colors indicate active genes or regulatory functions; gray indicates genes or regulatory functions that are not expressed, except
that in (B) gray and green color indicates regulatory functions that are active only after 30 h. (B) VFN of oral ectoderm (OE), early–mid gastrulation. We
include in this definition the ciliary band and the apical plate that at this time are not yet morphologically distinct from the rest of the OE. Soon after 28 h,
interference with Spdri mRNA translation begins to affect Spdri transcription (Table 2). Therefore, from this time on, Spdri appears able to regulate its own
transcription in the OE with no need for the initial oral activator. After 30 h, the Spdri-gsc activation loop is fully established, and the transcription of Spdri
and gsc now depends on the availability of their respective gene products in the OE. This provides a molecular-level description of the phenomenon of
“postgastrular commitment of the oral ectoderm.” From 30 h on, Spdri also activates otp and nkx2.1. Spgsc works as a repressor (Angerer et al., 2001):
therefore, the regulation of Spdri (and of Spdri target genes) by gsc must be via the repression of a gene encoding another repressor of Spdri, here “repressor
A.” Also after 28 h, the continuation of nk1 and otx1/2 expression in the OE requires Spdri. Conclusive data on the requirement of either gsc or Spdri
expression for the activation of gsc, nkx2.1, or otp were obtained only from 30 h on. (C) VFN for aboral ectoderm (AE). No expression of Spdri or gsc is
observed. Spec1 expression is allowed by the activity of Otx and CBF and the absence of any repressive activity (i.e., gsc, OER, and repressor b genes are
silent). (D) VFN for oral ectoderm excluding the apical plate (AP, in the panel title) and the ciliary band (CB, in the panel title). At 48 h, the repression of
Spec1 in the domain of the oral ectoderm depends on the Spdri-gsc system. The Gsc factor directly competes with Otx for the binding site in the Spec1
cis-regulatory element (Angerer et al., 2001). Thus, OER is no longer required. The pattern of expression of SpOtp is unknown. We assume that it is similar
to that in P. lividus (Di Bernardo et al., 1999). There, otp is expressed in the oral ectoderm but in a domain that excludes the AP and the CB. (E) VFN for
the apical region and ciliary band of the oral ectoderm. In this region, no gsc expression is observed (Angerer et al., 2001). Therefore, the activity of an
additional repressor (AR) is required to prevent “repressor A” from repressing Spdri. Also another repressor (Repressor B) is required to explain Spec1
repression downstream of Spdri (Fig. 5). A possibility exists that (in the apical plate) Repressor B and SpNK2.1 are in fact the same gene, given that both
genes are expressed in the apical plate and NK genes are known to act as repressors. However, a repressor for spec1 in the ciliary band is also required. For
simplicity, we assume that a single repressor acts throughout the whole region where gsc is not present to stop spec1 transcription. The expression of SpNK2.1,
NK1, and otx1/2 is restricted to the apical plate–ciliary band subregion. Control of SpNK2.1 by SpDri is likely direct, because several canonical binding
sites for an ARID class transcription factor have been observed near the promoter of the nkx2.1 gene (K.J.P., unpublished data).
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differentiation genes tested, that are normally expressed in
these cells while they yet lie within the vegetal plate. The
magnitude of these effects ranges from about 4-fold to about
15-fold depression by the time ingression occurs, scarcely
insignificant. But it is not yet known if any other skeleto-
genic regulatory genes are direct cis-regulatory targets of
the Spdri factor. There could be regulatory connections
between Spdri and some other, yet unknown genes that
produce the transcription factors driving skeletogenic gene
expression. Spdri is acting positively in this role (as in all
other contexts discovered in this work), since the effect of
the Spdri MASO is the same as the affect of introducing an
mRNA encoding an SpDri-engrailed fusion protein.
In summary, though its specific linkages into the micro-
mere/pmc GRN of Oliveri et al. (2002) are not yet known,
the approximate position of Spdri can be inferred. This gene
operates downstream of the pmar1 derepression system, and
more or less immediately upstream of the batteries of skel-
etogenic genes that execute the differentiated functions of
the pmcs.
GRN linkages in the postgastrular oral ectoderm
These experiments afford our first glimpse of the genetic
control system that from gastrulation onwards produces the
regulatory state specific to the embryonic oral ectoderm.
This territory has already been specified as such by the time
the Spdri gene is activated there (28 h; Fig. 2), and by
embryological criteria it has already been committed to oral
ectoderm fate (see Introduction). The GRN underlying the
progressive stages of primary oral ectoderm specification
remains unexplored. One could think that the function of the
postgastrular GRN that operates in the committed oral ec-
toderm is just to “maintain” the state of specfication earlier
installed, but that is far too passive a summary: We learn
here that “being oral ectoderm” requires a continuing, active
control process involving interactions of several different
transcriptional regulatory genes. Furthermore, although the
postgastrular oral ectoderm is no longer responsive to ex-
ternal perturbations such as microsurgical transplantation,
its particular regulatory state can be entirely wiped out and
the whole territory converted to aboral ectoderm if the
operation of the postgastrular oral ectoderm GRN is
blocked. This can be done by means of at least two different
internal perturbations. These are interference with gsc ex-
pression (Angerer et al., 2001) and interference with Spdri
expression (Fig. 5).
Fig. 11 is an initial stab at the structure of some elements
of the postgastrular oral ectoderm GRN. As before (see
Bolouri and Davidson, 2002; Davidson et al., 2002a,b), the
GRN is presented in two ways, as a “view from the ge-
nome” (VFG) in which all implied interactions amongst the
genes included are portrayed together, irrespective of when
and where they obtain (Fig. 11A); and as “views from the
nucleus, VFN,” (Fig. 11B–E). The VFG indicates the reg-
ulatory logic map encoded in the genomic DNA sequence.
The VFNs indicate how the regulatory logic map accounts
for the diverse regulatory states of different space/time
domains of the embryo. The evidence on which Fig. 11 is
based consists of data showing when and where the genes
included are expressed, much from other laboratories as
referenced in text; from the observations of Angerer et al.
(2001) on the role of gsc; from the QPCR measurements of
Table 2, and the experiments of Fig. 5, both of which
concern the effects of interfering with expression of Spdri
and from the experiments of Fig. 6. Fig. 11 is in the nature
of a testable theory for the control of oral ectoderm regu-
latory state, testable by cis-regulatory analysis of the genes
included, and by examination of its predictions with respect
to the spatial consequences of further perturbations of gene
expression. Needless to say, these tests have barely begun to
be done, but even so, Fig. 11 provides a useful if only
provisional organization of a large number of disparate
measurements and observations.
As in the micromere/pmc GRN, all of the linkages down-
stream of Spdri appear positive in sign, for the reasons
adduced in text. As Table 2 shows, the expression of Spdri
is required, directly or indirectly, by several other regulatory
genes in the GRN. A particularly interesting feature of the
GRN in Fig. 11 as a whole, is the use of negative as well as
positive inputs to generate the necessary spatial domains of
gene regulatory state, and to produce stabilization loops. At
the top of the diagrams in Fig. 11, in parallel with Spdri is
the gsc gene, which in contrast to Spdri appears to encode
a dedicated repressor (Angerer et al., 2001). Its domain of
expression initially overlaps that of Spdri, but as the apical
plate and the ciliary band become specified as separate
subregions (around 30 h), gsc expression is confined to the
remainder of the oral ectoderm. In their region of overlap-
ping expression, Spdri and gsc provide mutual positive
inputs for one another, and Spdri also positively autoregu-
lates itself. However, gsc is an obligate repressor, so in
order to account for the strong depression of Spdri activity
caused by gsc MASO (Table 2; 28–36 h) an intermediate
hypothetical repressor gene (“repressor a” in Fig. 11) must
be active between gsc and Spdri. In any case, gsc and Spdri
expression together produce a stabilization loop for the oral
ectoderm regulatory state. Note that the mutual interrela-
tionship between Spdri and gsc exists only in the oral
ectoderm (Table 1). In the micromere descendants gsc
MASO has no effect on Spdri expression (Table 1; nor for
that matter does gsc MASO affect any other of the regu-
latory genes active in the micromere lineage; data not
shown). The significance of the gsc-repressor a-Spdri link-
age portrayed in Fig. 11A would be that it is responsible for
keeping Spdri on in the oral ectoderm, while Repressor A
keeps this gene off everywhere else. This idea is represented
in the aboral ectoderm VFN of Fig. 11C.
Angerer et al. (2001) found that if gsc expression is
blocked, expression of the Spec1 gene, an aboral ectoderm
marker, spreads over the oral ectoderm. Their studies fur-
ther demonstrated that repression of Spec2a (whose expres-
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sion is regulated by a cassette similar to that of Spec1; Gan
et al., 1990) is a direct cis-regulatory interaction, taking
place at the Otx target sites where the Gsc factor also binds.
Fig. 5D shows that when Spdri expression is blocked the
same consequence obtains: Spec1 expression spreads over
the whole of the oral ectoderm. The mutual dependence of
Spdri and gsc displayed in Fig. 11 provides the explanation.
Gsc is the direct repressor of Spec1, and SpDri is a driver of
the gsc gene. Expression of both genes is required through-
out, or the oral ectoderm ceases to exist as such.
It is interesting that expression of two NK-class home-
odomain regulators comes to distinguish the apical plate,
where the nkx2.1 gene is expressed (Fig. 5E), from the
remainder of the oral ectoderm, in the lower portion of
which the nk1 gene is expressed (T. Minokawa and E.H.D.,
unpublished data). Fig. 11D and E shows that both genes are
positively controlled by Spdri, directly or indirectly, as
clearly indicated by the evidence of Table 2 and Fig. 5. The
gsc gene is not expressed in the apical plate not in the ciliary
band. But since blockade of Spdri expression derepresses
Spec1 in these territories as well as elsewhere in the oral
ectoderm (Fig. 5C), there must be another repressor of
Spec1 active in the apical plate and ciliary band that works
downstream of Spdri, in addition to gsc. This need is the
rationale for the “repressor b” gene in Fig. 11.
How is the spatial segregation of the various Spdri target
genes achieved, given that these genes are expressed in what
is only a portion of the overall Spdri expression domain?
For example, Spdri alone cannot be responsible for the
expression of nkx2.1 only in the apical plate, since Spdri
itself is also expressed in the rest of the OE and in the ciliary
band, where nkx2.1 is not. Spdri could work as a general
activator needed for the maintenance of gsc, nk1, nkx2.1,
otx1/2, and otp expression, and the borders of the domains
of expression of these genes would be defined through
spatial repression. Alternatively, Spdri may need to coop-
erate with a series of already spatially confined positive
factors, and the activation of each target gene would occur
only where Spdri and the specific cofactor are active to-
gether. In neither case would ectopic Spdri expression alone
necessarily suffice to cause coincident expression of target
genes. We experimentally tested the sufficiency of dri for
the expression of three of its target genes: gsc, nk1, and
nkx2.1, as illustrated in Fig. 6. The result confirms that Spdri
functions together with other regulators in the relevant cis-
regulatory elements of these genes, though whether these
are positive or negative will require further exploration to
determine.
We see, in summary, that while Spdri encodes a tran-
scriptional activator, its downstream target in the oral ecto-
derm GRN includes both negatively acting regulatory genes
(gsc, repressor a, and repressor b) and positively acting
regulatory genes. Some of these operate only in the apical
plate (nxk2.1), others only outside the apical plate (otp and
nk1), and others in both (the 1/2otx cis-regulatory system).
Embryological phenomenology: some regulatory
requirements for skeletogenesis, gastrulation, and
formation of the oral ectoderm
It has been understood for some years that the initial
expression of skeletogenic genes is an autonomously pro-
grammed consequence of micromere lineage differentia-
tion, but the actual pattern in which the skeleton is deposited
is not an autonomous pmc function. It depends on some sort
of spatial information, that is to say, signal, presented on the
inner ectodermal wall, which the pmcs detect and align
themselves in response to (Ettensohn, 1992; Ettensohn and
Ingersoll, 1992; McClay et al., 1992; Armstrong et al.,
1993; Armstrong and McClay, 1994; Peterson and McClay,
2002). Skeletal rod formation occurs following formation of
syncytial chains of pmcs along this wall. In S. purpuratus,
the skeletogenic foci initially coalesce at the base of the oral
ectoderm, on either side of the gut. There the body rods
begin their growth and elongation. Later on, projections
grow out at an angle from the initial pair of rods, the most
prominent example of which is the pair of oral rods. The
underlying pattern formed by the pmc’s depositing one of
the oral rods is visualized immunocytologically in Fig. 9J.
In the chimera of Fig. 9I, it can be seen that this piece of the
skeletal pattern is missing (dotted white lines), in conse-
quence of the presence of Spdri MASO in the oral ecto-
derm. It follows that Spdri expression in the oral ectoderm
is required for the presentation of the patterning signal to
which the pmcs producing the oral rods would normally
respond. However, in these same chimeras, the pmcs are
evidently able to pick up the signals on the vegetal floor of
the blastocoel with which they are initially confronted after
they ingress, since they form a normal-looking ring (Fig.
9E) and produce oral lateral characters in the right place,
thereafter some delay (Fig. 9H). The initial signals to which
the pmcs respond right after ingression may be expressed in
endodermal cells on the oral side of the vegetal pole. In any
case, the presentation of these signals does not depend on
whether Spdri is or is not expressed in the oral ectoderm.
A different outcome is seen in chimeras in which the rest
of the embryo is normal and only the pmcs contain Spdri
MASO. These pmcs are unable to read any patterning sig-
nals, and following ingression they wander aimlessly about
the blastocoel (Fig. 9C, F, and G). In other words, the
phenomenon of patterned skeletogenesis indeed requires
regulatory functions on the part of both ectoderm and skel-
etogenic mesenchyme. Curiously, the same gene, Spdri, is
needed for both parts of the process. The dual requirements
for Spdri expression converge at the sm30 gene: Fig. 10E–H
shows that if either pmcs or oral ectoderm suffer interfer-
ence with Spdri expression, sm30 is not transcribed at all at
late gastrula stage, though this is normally a time of active
sm30 expression (Fig. 10A–D).
A nonautonomous relation between the micromere lin-
eage and initial specification of the definitive oral ectoderm
can also be perceived through the lens of Spdri expression.
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In embryos from which the micromeres have been removed,
Spdri is never activated in the oral ectoderm (Fig. 10I and
J). Micromere removal severely impacts endomesodermal
specification (Ransick and Davidson, 1995; D.R.M., P. Ol-
iveri and E.H.D., unpublished data). No doubt the failure of
oral ectoderm specification seen here is an indirect effect of
loss of endomesodermal identity. There is much earlier
evidence from experimental embryology that specification
of the oral ectoderm requires signals from the adjacent
endoderm (reviewed by Davidson et al., 1998). Now we
have the activation of an oral ectoderm specific regulatory
gene to use as a marker of this previously inferred signaling
interaction.
Finally, we consider the visible process of gastrulation.
Since isolated vegetal plates initiate gastrulation (Ettensohn,
1984; Hardin and Cheng, 1986), the early phases of gastru-
lation must be an autonomously programmed function of
the endoderm. Indeed, recent experiments show that pertur-
bation of the expression of many endodermal regulatory
genes produce phenotypes that include failure of gastrula-
tion (Davidson et al., 2002a,b). Some such genes, such as
brachyury, directly control cytoskeletal mobility functions
needed for gastrulation (Gross and McClay, 2001; Rast et
al., 2002). But normal, on time endoderm specification in
turn requires a signal from the micromeres which continues
late into blastulation (Ransick and Davidson, 1993, 1995;
Minokawa and Amemiya, 1999; Ishizuka et al., 2001). Nei-
ther the early signal from the micromere lineages (4th to 6th
cleavage), nor the Notch signal to the prospective veg2
mesoderm (7th–9th cleavage; Sherwood and McClay, 1997,
1999; Sweet et al., 2002) can require expression of Spdri
since this gene is not yet active when these signals are
passed. But the late signal-dependent phase of Soxb1 clear-
ance (after 18.5 h) is indeed dependent on Spdri expression
in the micromere descendants, the surprising discovery il-
lustrated in Figs. 8 and 9A and B. Since it has the same
effect on the same target protein, Soxb1, the late and the
early signals from the micromere lineage could be mediated
by the same ligand/receptor combination. Note that the
chimera experiments of Figs. 9 and 10 provide a polarity to
the signaling phenomena discussed here. The micromeres
affect veg2, veg2 is known to affect specification of veg1
(Logan et al., 1999), and oral ectoderm specification in turn
depends in a nonautonomous manner on these prior signal-
ing events. They are all directed “upward” from the vegetal
pole of the embryo. Apparently normal gastrulation occurs
in chimeras consisting of two normal micromeres and
(therefore) normally specified endomesoderm, but Spdri
MASO poisoned oral ectoderm (Fig. 9G and H). So there is
no evidence for a signaling interaction needed for the nor-
mal gastrulation process that goes from the oral ectoderm
back to the vegetal plate.
A by-product of the chimera experiments is the unex-
pected observation (Figs. 9 and 10) that both MM/CE and
CM/ME chimeras gastrulate, though in distinctive ways
(Table 4). Yet whole embryos bearing the Spdri MASO
always fail to gastrulate. In the latter case, a general toxic
effect not confined to the domains of Spdri expression
could be invoked, although this can only partially explain
the effects observed. In embryos treated with Spdri
MASO, the whole blastula wall is thicker than normal,
indicating a cell shape change, which could adversely affect
the motility required for gastrulation. The same is true for
the CM/ME embryos (Fig. 9B) but in some manner the
defect is overcome within the limited domain of Soxb1
clearance mediated by the late signal from the normal mi-
cromeres in the chimeras. The observation that the MM/CE
chimeras build their archenterons with only two-thirds of
the normal number of cells (Table 4) is suggestive. Perhaps
in these embryos, the contribution of veg1 (which accounts
for a one-third of the cells in the definitive gut) to the
hindgut is lost. Veg1 cells are normally recruited to the
developing hindgut at around 30 h when, in S. purpuratus,
the mainly oral portion of this tier starts to invaginates
(Ransick et al., 1998). It is interesting that at the same time
the pattern of expression of krl shifts from a pan-veg1 to an
oral-only veg1 mode of expression and that this shift is
never observed in the Spdri MASO-injected embryos.
Other possible explanations invoke mechanisms of reg-
ulative development, that is, the use of naturally occurring
interterritorial interactions in new contexts provoked by
experimental manipulation. To choose amongst the possi-
bilities would require additional experiments, tangential to
our main interest in this study: the oral ectoderm GRN, and
the role played therein by the Spdri regulatory gene.
Conclusions
To summarize, Spdri acts both autonomously and non-
autonomously in each of its domains of expression. Within
the GRNs of each it controls other genes, an autonomous
function. This aspect of its function includes control of
skeletogenic gene expression in the micromere descendants
and of the expression of various regulatory genes in the oral
ectoderm. Spdri expression is also required (directly or
indirectly) for several nonautonomous processes to occur in
the embryo. These include expression of a signal in the
micromere descendants before ingression, expression of a
skeletogenic patterning signal receptor in pmcs after ingres-
sion, and expression of the patterning signal itself in the oral
ectoderm. One of the genes controlled by Spdri in the oral
ectoderm, otp, may itself have the nonautonomous function
of presenting a patterning signal to certain of the pmcs (Di
Bernardo et al., 1999). The autonomous functions of Spdri
in both micromere/pmc and oral ectoderm GRNs are clearly
important, for in the absence of Spdri expression neither
GRN works. But the nonautonomous functions have the
additional quality that they open the door to understanding
at the GRN level some of the phenomenology of morpho-
genesis that had been revealed earlier by experimental em-
bryology.
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